重症COVID-19幸存者持续性疲劳、乏力及骨骼肌线粒体异常
该前瞻性观察研究分两阶段:第一阶段纳入120例重症COVID-19幸存者,出院后44±17天在ICU康复门诊评估身体功能;第二阶段为嵌套队列,11例患者于出院后267±98天接受全面肌肉功能评估和肌肉活检,并与非COVID对照比较。结果显示93%患者报告全身性疲劳,6分钟步行试验平均218±151米(为预测值的45%±30%);COVID患者肌肉组织M2样巨噬细胞和卫星细胞丰度更高,线粒体复合物II和IV活性更低。作者认为骨骼肌修复异常和线粒体活性改变与ICU幸存者的长期功能障碍相关。
要点
- 120例重症COVID-19幸存者出院后44±17天随访,93%报告全身性疲劳,6分钟步行试验平均218±151米(为预测值的45%±30%)。
- 该队列中98例(82%)需要机械通气,机械通气中位时长14天(IQR 9-21天),中位APACHE-II评分24.0(IQR 16-29)。
- 11例患者于出院后267±98天接受肌肉活检,COVID患者肌肉组织M2样巨噬细胞和卫星细胞丰度高于非COVID对照。
- 同一活检显示COVID患者骨骼肌线粒体复合物II和复合物IV活性低于对照。
- 作者认为骨骼肌修复异常和线粒体活性改变与ICU幸存者的长期功能障碍相关。
适用人群与场景
- 重症COVID-19幸存者,在ICU康复门诊参加短期随访(出院后44±17天)。
- 其中11例纳入长期评估和肌肉活检(出院后267±98天),并与非COVID对照比较。
研究设计与关键结果
- 研究设计为前瞻性观察研究,分两阶段:第一阶段为重症COVID-19幸存者参加身体功能评估;第二阶段为嵌套队列进行肌肉活检并与非COVID对照比较。
- 第一阶段纳入120例患者,中位年龄56岁(IQR 42-65岁),女性43%,少数族裔33%,随访时间为出院后44±17天。
- 中位APACHE-II评分24.0(IQR 16-29),98例(82%)接受机械通气,中位通气时长14天(IQR 9-21天)。
- 短期随访时93%患者报告全身性疲劳,6分钟步行试验平均218±151米(为预测值的45%±30%)。
- 11例患者于出院后267±98天接受肌肉活检,COVID患者肌肉组织M2样巨噬细胞和卫星细胞丰度高于对照,线粒体复合物II和复合物IV活性低于对照。
证据类型、等级与局限
- 证据类型:前瞻性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为骨骼肌修复异常和线粒体活性改变与ICU幸存者的长期功能障碍相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Persistent skeletal muscle dysfunction in survivors of critical illness due to acute respiratory failure is common, but biological data elucidating underlying mechanisms are limited. The objective of this study was to elucidate the prevalence of skeletal muscle weakness and fatigue in survivors of critical illness due to COVID-19 and determine if cellular changes associate with persistent skeletal muscle dysfunction.
DESIGN: A prospective observational study in two phases: 1) survivors of critical COVID-19 participating in physical outcome measures while attending an ICU Recovery Clinic at short-term follow-up and 2) a nested cohort of patients performed comprehensive muscle and physical function assessments with a muscle biopsy; data were compared with non-COVID controls.
SETTING: ICU Recovery Clinic and clinical laboratory.
PATIENTS/SUBJECTS: Survivors of critical COVID-19 and non-COVID controls.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: One hundred twenty patients with a median of 56 years old (interquartile range [IQR], 42-65 yr old), 43% female, and 33% individuals of underrepresented race attended follow-up 44 ± 17 days after discharge. Patients had a median Acute Physiology and Chronic Health Evaluation-II score of 24.0 (IQR, 16-29) and 98 patients (82%) required mechanical ventilation with a median duration of 14 days (IQR, 9-21 d). At short-term follow-up significant physical dysfunction was observed with 93% of patients reporting generalized fatigue and performing mean 218 ± 151 meters on 6-minute walk test (45% ± 30% of predicted). Eleven patients from this group agreed to participate in long-term assessment and muscle biopsy occurring a mean 267 ± 98 days after discharge. Muscle tissue from COVID exhibited a greater abundance of M2-like macrophages and satellite cells and lower activity of mitochondrial complex II and complex IV compared with controls.
CONCLUSIONS: Our findings suggest that aberrant repair and altered mitochondrial activity in skeletal muscle associates with long-term impairments in patients surviving an ICU admission for COVID-19.
参考来源
- Mayer KP, Ismaeel A, Kalema AG, et al. Persistent Fatigue, Weakness, and Aberrant Muscle Mitochondria in Survivors of Critical COVID-19. Crit Care Explor. 2024. PMID: 39412208. doi:10.1097/CCE.0000000000001164
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。